Global Cardiac Biomarkers Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 03-Nov-2022
No. of pages: 106
Inquire Before Buying

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Cardiac Biomarkers companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Cardiac Biomarkers market. Further, it explains the major drivers and regional dynamics of the global Cardiac Biomarkers market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Abbott

- Abbott

- F. Hoffmann-La Roche

- Advanced ImmunoChemical

- AgPlus Diagnostics

- BG Medicine

- BioLegend

- bioMérieux

- Bio-Rad Laboratories

- BODITECH MED

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Cardiac Biomarkers Segment by Type

- Troponin

- CK-MB

- Natriuretic Peptides - BNP and NT-proBNP

- Myoglobin

- Others

Cardiac Biomarkers Segment by Application

- Acute Coronary Syndrome

- Myocardial Infarction

- Congestive Heart Failure

- Others

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Cardiac Biomarkers market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Cardiac Biomarkers market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Cardiac Biomarkers, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cardiac Biomarkers, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cardiac Biomarkers revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Cardiac Biomarkers market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Cardiac Biomarkers revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Abbott, Abbott, F. Hoffmann-La Roche, Advanced ImmunoChemical, AgPlus Diagnostics, BG Medicine, BioLegend, bioMérieux and Bio-Rad Laboratories, etc.

Global Cardiac Biomarkers Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cardiac Biomarkers Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Troponin
1.2.3 CK-MB
1.2.4 Natriuretic Peptides - BNP and NT-proBNP
1.2.5 Myoglobin
1.2.6 Others
1.3 Market by Application
1.3.1 Global Cardiac Biomarkers Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Acute Coronary Syndrome
1.3.3 Myocardial Infarction
1.3.4 Congestive Heart Failure
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Cardiac Biomarkers Market Size (2017-2028)
2.2 Cardiac Biomarkers Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Cardiac Biomarkers Market Size by Region (2017-2022)
2.4 Global Cardiac Biomarkers Market Size Forecast by Region (2023-2028)
2.5 Global Top Cardiac Biomarkers Countries Ranking by Market Size
3 Cardiac Biomarkers Competitive by Company
3.1 Global Cardiac Biomarkers Revenue by Players
3.1.1 Global Cardiac Biomarkers Revenue by Players (2017-2022)
3.1.2 Global Cardiac Biomarkers Market Share by Players (2017-2022)
3.2 Global Cardiac Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Cardiac Biomarkers Revenue
3.4 Global Cardiac Biomarkers Market Concentration Ratio
3.4.1 Global Cardiac Biomarkers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cardiac Biomarkers Revenue in 2021
3.5 Global Cardiac Biomarkers Key Players Head office and Area Served
3.6 Key Players Cardiac Biomarkers Product Solution and Service
3.7 Date of Enter into Cardiac Biomarkers Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Cardiac Biomarkers Breakdown Data by Type
4.1 Global Cardiac Biomarkers Historic Revenue by Type (2017-2022)
4.2 Global Cardiac Biomarkers Forecasted Revenue by Type (2023-2028)
5 Global Cardiac Biomarkers Breakdown Data by Application
5.1 Global Cardiac Biomarkers Historic Market Size by Application (2017-2022)
5.2 Global Cardiac Biomarkers Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cardiac Biomarkers Revenue by Company (2020-2022)
6.2 North America Cardiac Biomarkers Revenue by Type (2017-2028)
6.3 North America Cardiac Biomarkers Revenue by Application (2017-2028)
6.4 North America Cardiac Biomarkers Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Cardiac Biomarkers Revenue by Company (2020-2022)
7.2 Europe Cardiac Biomarkers Revenue by Type (2017-2028)
7.3 Europe Cardiac Biomarkers Revenue by Application (2017-2028)
7.4 Europe Cardiac Biomarkers Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Cardiac Biomarkers Revenue by Company (2020-2022)
8.2 Asia Pacific Cardiac Biomarkers Revenue by Type (2017-2028)
8.3 Asia Pacific Cardiac Biomarkers Revenue by Application (2017-2028)
8.4 Asia Pacific Cardiac Biomarkers Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Cardiac Biomarkers Revenue by Company (2020-2022)
9.2 Latin America Cardiac Biomarkers Revenue by Type (2017-2028)
9.3 Latin America Cardiac Biomarkers Revenue by Application (2017-2028)
9.4 Latin America Cardiac Biomarkers Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Cardiac Biomarkers Revenue by Company (2020-2022)
10.2 Middle East and Africa Cardiac Biomarkers Revenue by Type (2017-2028)
10.3 Middle East and Africa Cardiac Biomarkers Revenue by Application (2017-2028)
10.4 Middle East and Africa Cardiac Biomarkers Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Cardiac Biomarkers Products and Services
11.1.4 Abbott Cardiac Biomarkers Revenue in Cardiac Biomarkers Business (2017-2022)
11.1.5 Abbott Cardiac Biomarkers SWOT Analysis
11.1.6 Abbott Recent Developments
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Cardiac Biomarkers Products and Services
11.2.4 Abbott Cardiac Biomarkers Revenue in Cardiac Biomarkers Business (2017-2022)
11.2.5 Abbott Cardiac Biomarkers SWOT Analysis
11.2.6 Abbott Recent Developments
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Details
11.3.2 F. Hoffmann-La Roche Business Overview
11.3.3 F. Hoffmann-La Roche Cardiac Biomarkers Products and Services
11.3.4 F. Hoffmann-La Roche Cardiac Biomarkers Revenue in Cardiac Biomarkers Business (2017-2022)
11.3.5 F. Hoffmann-La Roche Cardiac Biomarkers SWOT Analysis
11.3.6 F. Hoffmann-La Roche Recent Developments
11.4 Advanced ImmunoChemical
11.4.1 Advanced ImmunoChemical Company Details
11.4.2 Advanced ImmunoChemical Business Overview
11.4.3 Advanced ImmunoChemical Cardiac Biomarkers Products and Services
11.4.4 Advanced ImmunoChemical Cardiac Biomarkers Revenue in Cardiac Biomarkers Business (2017-2022)
11.4.5 Advanced ImmunoChemical Cardiac Biomarkers SWOT Analysis
11.4.6 Advanced ImmunoChemical Recent Developments
11.5 AgPlus Diagnostics
11.5.1 AgPlus Diagnostics Company Details
11.5.2 AgPlus Diagnostics Business Overview
11.5.3 AgPlus Diagnostics Cardiac Biomarkers Products and Services
11.5.4 AgPlus Diagnostics Cardiac Biomarkers Revenue in Cardiac Biomarkers Business (2017-2022)
11.5.5 AgPlus Diagnostics Cardiac Biomarkers SWOT Analysis
11.5.6 AgPlus Diagnostics Recent Developments
11.6 BG Medicine
11.6.1 BG Medicine Company Details
11.6.2 BG Medicine Business Overview
11.6.3 BG Medicine Cardiac Biomarkers Products and Services
11.6.4 BG Medicine Cardiac Biomarkers Revenue in Cardiac Biomarkers Business (2017-2022)
11.6.5 BG Medicine Cardiac Biomarkers SWOT Analysis
11.6.6 BG Medicine Recent Developments
11.7 BioLegend
11.7.1 BioLegend Company Details
11.7.2 BioLegend Business Overview
11.7.3 BioLegend Cardiac Biomarkers Products and Services
11.7.4 BioLegend Cardiac Biomarkers Revenue in Cardiac Biomarkers Business (2017-2022)
11.7.5 BioLegend Cardiac Biomarkers SWOT Analysis
11.7.6 BioLegend Recent Developments
11.8 bioMérieux
11.8.1 bioMérieux Company Details
11.8.2 bioMérieux Business Overview
11.8.3 bioMérieux Cardiac Biomarkers Products and Services
11.8.4 bioMérieux Cardiac Biomarkers Revenue in Cardiac Biomarkers Business (2017-2022)
11.8.5 bioMérieux Cardiac Biomarkers SWOT Analysis
11.8.6 bioMérieux Recent Developments
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories Company Details
11.9.2 Bio-Rad Laboratories Business Overview
11.9.3 Bio-Rad Laboratories Cardiac Biomarkers Products and Services
11.9.4 Bio-Rad Laboratories Cardiac Biomarkers Revenue in Cardiac Biomarkers Business (2017-2022)
11.9.5 Bio-Rad Laboratories Cardiac Biomarkers SWOT Analysis
11.9.6 Bio-Rad Laboratories Recent Developments
11.10 BODITECH MED
11.10.1 BODITECH MED Company Details
11.10.2 BODITECH MED Business Overview
11.10.3 BODITECH MED Cardiac Biomarkers Products and Services
11.10.4 BODITECH MED Cardiac Biomarkers Revenue in Cardiac Biomarkers Business (2017-2022)
11.10.5 BODITECH MED Cardiac Biomarkers SWOT Analysis
11.10.6 BODITECH MED Recent Developments
12 Cardiac Biomarkers Market Dynamics
12.1 Cardiac Biomarkers Market Trends
12.2 Cardiac Biomarkers Market Drivers
12.3 Cardiac Biomarkers Market Challenges
12.4 Cardiac Biomarkers Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Cardiac Biomarkers Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Troponin
Table 3. Key Players of CK-MB
Table 4. Key Players of Natriuretic Peptides - BNP and NT-proBNP
Table 5. Key Players of Myoglobin
Table 6. Key Players of Others
Table 7. Global Cardiac Biomarkers Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Cardiac Biomarkers Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 9. Global Cardiac Biomarkers Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Cardiac Biomarkers Revenue Market Share by Region (2017-2022)
Table 11. Global Cardiac Biomarkers Revenue by Players (2017-2022) & (US$ Million)
Table 12. Global Cardiac Biomarkers Market Share by Players (2017-2022)
Table 13. Global Top Cardiac Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiac Biomarkers as of 2021)
Table 14. Ranking of Global Top Cardiac Biomarkers Companies by Revenue (US$ Million) in 2021
Table 15. Global 5 Largest Players Market Share by Cardiac Biomarkers Revenue (CR5 and HHI) & (2017-2022)
Table 16. Key Players Headquarters and Area Served
Table 17. Key Players Cardiac Biomarkers Product Solution and Service
Table 18. Date of Key Manufacturers Enter into Cardiac Biomarkers Market
Table 19. Mergers & Acquisitions, Expansion Plans
Table 20. Global Cardiac Biomarkers Market Size by Type (2017-2022) & (US$ Million)
Table 21. Global Cardiac Biomarkers Revenue Market Share by Type (2017-2022)
Table 22. Global Cardiac Biomarkers Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 23. Global Cardiac Biomarkers Revenue Market Share by Type (2023-2028)
Table 24. Global Cardiac Biomarkers Market Size by Application (2017-2022) & (US$ Million)
Table 25. Global Cardiac Biomarkers Revenue Market Share by Application (2017-2022)
Table 26. Global Cardiac Biomarkers Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 27. Global Cardiac Biomarkers Revenue Market Share by Application (2023-2028)
Table 28. North America Cardiac Biomarkers Revenue by Company (2020-2022) & (US$ Million)
Table 29. North America Cardiac Biomarkers Revenue by Type (2017-2022) & (US$ Million)
Table 30. North America Cardiac Biomarkers Revenue by Type (2023-2028) & (US$ Million)
Table 31. North America Cardiac Biomarkers Revenue by Application (2017-2022) & (US$ Million)
Table 32. North America Cardiac Biomarkers Revenue by Application (2023-2028) & (US$ Million)
Table 33. North America Cardiac Biomarkers Revenue by Country (2017-2022) & (US$ Million)
Table 34. North America Cardiac Biomarkers Revenue by Country (2023-2028) & (US$ Million)
Table 35. Europe Cardiac Biomarkers Revenue by Company (2020-2022) & (US$ Million)
Table 36. Europe Cardiac Biomarkers Revenue by Type (2017-2022) & (US$ Million)
Table 37. Europe Cardiac Biomarkers Revenue by Type (2023-2028) & (US$ Million)
Table 38. Europe Cardiac Biomarkers Revenue by Application (2017-2022) & (US$ Million)
Table 39. Europe Cardiac Biomarkers Revenue by Application (2023-2028) & (US$ Million)
Table 40. Europe Cardiac Biomarkers Revenue by Country (2017-2022) & (US$ Million)
Table 41. Europe Cardiac Biomarkers Revenue by Country (2023-2028) & (US$ Million)
Table 42. Asia Pacific Cardiac Biomarkers Revenue by Company (2020-2022) & (US$ Million)
Table 43. Asia Pacific Cardiac Biomarkers Revenue by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Cardiac Biomarkers Revenue by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Cardiac Biomarkers Revenue by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Cardiac Biomarkers Revenue by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Cardiac Biomarkers Revenue by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Cardiac Biomarkers Revenue by Region (2023-2028) & (US$ Million)
Table 49. Latin America Cardiac Biomarkers Revenue by Company (2020-2022) & (US$ Million)
Table 50. Latin America Cardiac Biomarkers Revenue by Type (2017-2022) & (US$ Million)
Table 51. Latin America Cardiac Biomarkers Revenue by Type (2023-2028) & (US$ Million)
Table 52. Latin America Cardiac Biomarkers Revenue by Application (2017-2022) & (US$ Million)
Table 53. Latin America Cardiac Biomarkers Revenue by Application (2023-2028) & (US$ Million)
Table 54. Latin America Cardiac Biomarkers Revenue by Country (2017-2022) & (US$ Million)
Table 55. Latin America Cardiac Biomarkers Revenue by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Cardiac Biomarkers Revenue by Company (2020-2022) & (US$ Million)
Table 57. Middle East and Africa Cardiac Biomarkers Revenue by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Cardiac Biomarkers Revenue by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Cardiac Biomarkers Revenue by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Cardiac Biomarkers Revenue by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Cardiac Biomarkers Revenue by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Cardiac Biomarkers Revenue by Country (2023-2028) & (US$ Million)
Table 63. Abbott Company Details
Table 64. Abbott Business Overview
Table 65. Abbott Cardiac Biomarkers Product and Services
Table 66. Abbott Cardiac Biomarkers Revenue in Cardiac Biomarkers Business (2017-2022) & (US$ Million)
Table 67. Abbott Cardiac Biomarkers SWOT Analysis
Table 68. Abbott Recent Developments
Table 69. Abbott Company Details
Table 70. Abbott Business Overview
Table 71. Abbott Cardiac Biomarkers Product and Services
Table 72. Abbott Cardiac Biomarkers Revenue in Cardiac Biomarkers Business (2017-2022) & (US$ Million)
Table 73. Abbott Cardiac Biomarkers SWOT Analysis
Table 74. Abbott Recent Developments
Table 75. F. Hoffmann-La Roche Company Details
Table 76. F. Hoffmann-La Roche Business Overview
Table 77. F. Hoffmann-La Roche Cardiac Biomarkers Product and Services
Table 78. F. Hoffmann-La Roche Cardiac Biomarkers Revenue in Cardiac Biomarkers Business (2017-2022) & (US$ Million)
Table 79. F. Hoffmann-La Roche Cardiac Biomarkers SWOT Analysis
Table 80. F. Hoffmann-La Roche Recent Developments
Table 81. Advanced ImmunoChemical Company Details
Table 82. Advanced ImmunoChemical Business Overview
Table 83. Advanced ImmunoChemical Cardiac Biomarkers Product and Services
Table 84. Advanced ImmunoChemical Cardiac Biomarkers Revenue in Cardiac Biomarkers Business (2017-2022) & (US$ Million)
Table 85. Advanced ImmunoChemical Cardiac Biomarkers SWOT Analysis
Table 86. Advanced ImmunoChemical Recent Developments
Table 87. AgPlus Diagnostics Company Details
Table 88. AgPlus Diagnostics Business Overview
Table 89. AgPlus Diagnostics Cardiac Biomarkers Product and Services
Table 90. AgPlus Diagnostics Cardiac Biomarkers Revenue in Cardiac Biomarkers Business (2017-2022) & (US$ Million)
Table 91. AgPlus Diagnostics Cardiac Biomarkers SWOT Analysis
Table 92. AgPlus Diagnostics Recent Developments
Table 93. BG Medicine Company Details
Table 94. BG Medicine Business Overview
Table 95. BG Medicine Cardiac Biomarkers Product and Services
Table 96. BG Medicine Cardiac Biomarkers Revenue in Cardiac Biomarkers Business (2017-2022) & (US$ Million)
Table 97. BG Medicine Cardiac Biomarkers SWOT Analysis
Table 98. BG Medicine Recent Developments
Table 99. BioLegend Company Details
Table 100. BioLegend Business Overview
Table 101. BioLegend Cardiac Biomarkers Product and Services
Table 102. BioLegend Cardiac Biomarkers Revenue in Cardiac Biomarkers Business (2017-2022) & (US$ Million)
Table 103. BioLegend Cardiac Biomarkers SWOT Analysis
Table 104. BioLegend Recent Developments
Table 105. bioMérieux Company Details
Table 106. bioMérieux Business Overview
Table 107. bioMérieux Cardiac Biomarkers Product and Services
Table 108. bioMérieux Cardiac Biomarkers Revenue in Cardiac Biomarkers Business (2017-2022) & (US$ Million)
Table 109. bioMérieux Cardiac Biomarkers SWOT Analysis
Table 110. bioMérieux Recent Developments
Table 111. Bio-Rad Laboratories Company Details
Table 112. Bio-Rad Laboratories Business Overview
Table 113. Bio-Rad Laboratories Cardiac Biomarkers Product and Services
Table 114. Bio-Rad Laboratories Cardiac Biomarkers Revenue in Cardiac Biomarkers Business (2017-2022) & (US$ Million)
Table 115. Bio-Rad Laboratories Cardiac Biomarkers SWOT Analysis
Table 116. Bio-Rad Laboratories Recent Developments
Table 117. BODITECH MED Company Details
Table 118. BODITECH MED Business Overview
Table 119. BODITECH MED Cardiac Biomarkers Product and Services
Table 120. BODITECH MED Cardiac Biomarkers Revenue in Cardiac Biomarkers Business (2017-2022) & (US$ Million)
Table 121. BODITECH MED Cardiac Biomarkers SWOT Analysis
Table 122. BODITECH MED Recent Developments
Table 123. Cardiac Biomarkers Market Trends
Table 124. Cardiac Biomarkers Market Drivers
Table 125. Cardiac Biomarkers Market Challenges
Table 126. Cardiac Biomarkers Market Restraints
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cardiac Biomarkers Sales Market Share by Type: 2021 VS 2028
Figure 2. Troponin Features
Figure 3. CK-MB Features
Figure 4. Natriuretic Peptides - BNP and NT-proBNP Features
Figure 5. Myoglobin Features
Figure 6. Others Features
Figure 7. Global Cardiac Biomarkers Sales Market Share by Application: 2021 VS 2028
Figure 8. Acute Coronary Syndrome Case Studies
Figure 9. Myocardial Infarction Case Studies
Figure 10. Congestive Heart Failure Case Studies
Figure 11. Others Case Studies
Figure 12. Cardiac Biomarkers Report Years Considered
Figure 13. Global Cardiac Biomarkers Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Cardiac Biomarkers Market Size 2017-2028 (US$ Million)
Figure 15. Global Cardiac Biomarkers Market Size Market Share by Region: 2021 VS 2028
Figure 16. Global Cardiac Biomarkers Revenue Market Share by Region in 2017 VS 2022
Figure 17. Global Top 10 Cardiac Biomarkers Countries Ranking by Market Size (US$ Million) in 2021
Figure 18. Global Cardiac Biomarkers Market Share by Players in 2021
Figure 19. Global Top Cardiac Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiac Biomarkers as of 2021)
Figure 20. The Top 10 and 5 Players Market Share by Cardiac Biomarkers Revenue in 2021
Figure 21. North America Cardiac Biomarkers Revenue Market Share by Company in 2021
Figure 22. North America Cardiac Biomarkers Revenue Market Share by Type (2017-2028)
Figure 23. North America Cardiac Biomarkers Revenue Market Share by Application (2017-2028)
Figure 24. North America Cardiac Biomarkers Revenue Share by Country (2017-2028)
Figure 25. U.S. Cardiac Biomarkers Revenue (2017-2028) & (US$ Million)
Figure 26. Canada Cardiac Biomarkers Revenue (2017-2028) & (US$ Million)
Figure 27. Europe Cardiac Biomarkers Revenue Market Share by Company in 2021
Figure 28. Europe Cardiac Biomarkers Revenue Market Share by Type (2017-2028)
Figure 29. Europe Cardiac Biomarkers Revenue Market Share by Application (2017-2028)
Figure 30. Europe Cardiac Biomarkers Revenue Share by Country (2017-2028)
Figure 31. Germany Cardiac Biomarkers Revenue (2017-2028) & (US$ Million)
Figure 32. France Cardiac Biomarkers Revenue (2017-2028) & (US$ Million)
Figure 33. U.K. Cardiac Biomarkers Revenue (2017-2028) & (US$ Million)
Figure 34. Italy Cardiac Biomarkers Revenue (2017-2028) & (US$ Million)
Figure 35. Russia Cardiac Biomarkers Revenue (2017-2028) & (US$ Million)
Figure 36. Asia Pacific Cardiac Biomarkers Revenue Market Share by Company in 2021
Figure 37. Asia Pacific Cardiac Biomarkers Revenue Market Share by Type (2017-2028)
Figure 38. Asia Pacific Cardiac Biomarkers Revenue Market Share by Application (2017-2028)
Figure 39. Asia Pacific Cardiac Biomarkers Revenue Share by Region (2017-2028)
Figure 40. China Cardiac Biomarkers Revenue (2017-2028) & (US$ Million)
Figure 41. Japan Cardiac Biomarkers Revenue (2017-2028) & (US$ Million)
Figure 42. South Korea Cardiac Biomarkers Revenue (2017-2028) & (US$ Million)
Figure 43. India Cardiac Biomarkers Revenue (2017-2028) & (US$ Million)
Figure 44. Australia Cardiac Biomarkers Revenue (2017-2028) & (US$ Million)
Figure 45. Taiwan Cardiac Biomarkers Revenue (2017-2028) & (US$ Million)
Figure 46. Indonesia Cardiac Biomarkers Revenue (2017-2028) & (US$ Million)
Figure 47. Thailand Cardiac Biomarkers Revenue (2017-2028) & (US$ Million)
Figure 48. Malaysia Cardiac Biomarkers Revenue (2017-2028) & (US$ Million)
Figure 49. Philippines Cardiac Biomarkers Revenue (2017-2028) & (US$ Million)
Figure 50. Vietnam Cardiac Biomarkers Revenue (2017-2028) & (US$ Million)
Figure 51. Latin America Cardiac Biomarkers Revenue Market Share by Company in 2021
Figure 52. Latin America Cardiac Biomarkers Revenue Market Share by Type (2017-2028)
Figure 53. Latin America Cardiac Biomarkers Revenue Market Share by Application (2017-2028)
Figure 54. Latin America Cardiac Biomarkers Revenue Share by Country (2017-2028)
Figure 55. Mexico Cardiac Biomarkers Revenue (2017-2028) & (US$ Million)
Figure 56. Brazil Cardiac Biomarkers Revenue (2017-2028) & (US$ Million)
Figure 57. Argentina Cardiac Biomarkers Revenue (2017-2028) & (US$ Million)
Figure 58. Middle East and Africa Cardiac Biomarkers Revenue Market Share by Company in 2021
Figure 59. Middle East and Africa Cardiac Biomarkers Revenue Market Share by Type (2017-2028)
Figure 60. Middle East and Africa Cardiac Biomarkers Revenue Market Share by Application (2017-2028)
Figure 61. Middle East and Africa Cardiac Biomarkers Revenue Share by Country (2017-2028)
Figure 62. Turkey Cardiac Biomarkers Revenue (2017-2028) & (US$ Million)
Figure 63. Saudi Arabia Cardiac Biomarkers Revenue (2017-2028) & (US$ Million)
Figure 64. U.A.E Cardiac Biomarkers Revenue (2017-2028) & (US$ Million)
Figure 65. Abbott Revenue Growth Rate in Cardiac Biomarkers Business (2017-2022)
Figure 66. Abbott Revenue Growth Rate in Cardiac Biomarkers Business (2017-2022)
Figure 67. F. Hoffmann-La Roche Revenue Growth Rate in Cardiac Biomarkers Business (2017-2022)
Figure 68. Advanced ImmunoChemical Revenue Growth Rate in Cardiac Biomarkers Business (2017-2022)
Figure 69. AgPlus Diagnostics Revenue Growth Rate in Cardiac Biomarkers Business (2017-2022)
Figure 70. BG Medicine Revenue Growth Rate in Cardiac Biomarkers Business (2017-2022)
Figure 71. BioLegend Revenue Growth Rate in Cardiac Biomarkers Business (2017-2022)
Figure 72. bioMérieux Revenue Growth Rate in Cardiac Biomarkers Business (2017-2022)
Figure 73. Bio-Rad Laboratories Revenue Growth Rate in Cardiac Biomarkers Business (2017-2022)
Figure 74. BODITECH MED Revenue Growth Rate in Cardiac Biomarkers Business (2017-2022)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
  • Global Renal Biomarkers Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 89
    Renal biomarkers help diagnose or identify the patients at risk of developing kidney diseases, by measuring their blood or urine levels. They are commonly released in acute or chronic kidney injuries, which are characterized by the rapid or gradual loss of kidney function resulting into serous clinical implications. Highlights The global Renal Biomarkers market was valued at US$ 1233.2 million in 2022 and is anticipated to reach US$ 1643.2 million by 2029, witnessing a CAGR......
  • Global Biomarkers Market Research Report 2023
    Published: 07-Jan-2023        Price: US 2900 Onwards        Pages: 80
    In biological system, it means to calculate the whole number by marking part of individuals. Highlights The global Biomarkers market was valued at US$ 72910 million in 2022 and is anticipated to reach US$ 165160 million by 2029, witnessing a CAGR of 14.6% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. North America is the largest consumption place, with a consumption market sha......
  • Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Research Report 2023
    Published: 07-Jan-2023        Price: US 2900 Onwards        Pages: 100
    A biomarker is, according to the US National Institutes of Health, "a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention." Biomarkers make take the form of cellular characteristics, metabolites (e.g. sugars, lipids and hormones), molecular variations, or physical features (e.g., clinical symptoms) and are assessed accordingly, via measurement, annotation, d......
  • Global Biomarker (Medicine) Market Research Report 2022 - Market Size, Current Insights and Development Trends
    Published: 27-Dec-2022        Price: US 3450 Onwards        Pages: 113
    Biomarkers (short for biological markers) are biological measures of a biological state. By definition, a biomarker is "a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes or pharmacological responses to a therapeutic intervention." The report focuses on the Biomarker (Medicine) market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and d......
  • Renal Biomarkers: Technologies and Global Markets
    Published: 16-Dec-2022        Price: US 5500 Onwards        Pages: 93
    Report Scope: This report incorporates an in-depth analysis of the renal biomarker market, including market estimations and trends through 2021. Major players, competitive intelligence, innovative technologies, market dynamics and regional opportunities are discussed in detail. The report examines recent developments and product portfolios of major players. The patent analysis focuses on technological trends in recent years in regions such as the U.S., Europe, and Japan. The report ......
  • Global Cancer Biomarkers Market Research Report 2022 - Market Size, Current Insights and Development Trends
    Published: 29-Nov-2022        Price: US 3450 Onwards        Pages: 101
    The report focuses on the Cancer Biomarkers market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreove......
  • Global Biomarkers Market Research Report 2022 - Market Size, Current Insights and Development Trends
    Published: 24-Nov-2022        Price: US 3450 Onwards        Pages: 101
    The report focuses on the Biomarkers market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, cust......
  • Global Cardiac Biomarkers Market Research Report 2022 - Market Size, Current Insights and Development Trends
    Published: 17-Nov-2022        Price: US 3450 Onwards        Pages: 115
    The report focuses on the Cardiac Biomarkers market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreov......
  • Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Research Report 2022 - Market Size, Current Insights and Development Trends
    Published: 03-Nov-2022        Price: US 3450 Onwards        Pages: 120
    Biomarkers are an objective measure of measurement and assessment as indicators of normal biological processes, pathogenic processes or pharmacological responses to therapeutic interventions. Biomarkers take the form of cell characteristics, metabolites (such as sugars, lipids and hormones), molecular changes or physical characteristics (such as clinical symptoms) and are evaluated accordingly by measurements, annotations, documents and images. The report focuses on the Commercial......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs